KLK3 and prostate cancer: On the other hand, the AUC to predict clinically significant prostate cancer was 0.64 (95% CI 0.59–0.69, P < 0.001) for PSA and 0.78 (95% CI 0.74–0.82) for PSAD (Fig. 1B).